APA (7th ed.) Citation

Charalampous, C., Doucette, K., Chappell, A., & Vesole, D. H. (2024). Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression. Leukemia & Lymphoma, 65(12), 1901-1904. https://doi.org/10.1080/10428194.2024.2381647

Chicago Style (17th ed.) Citation

Charalampous, Charalampos, Kimberley Doucette, Aimee Chappell, and David H. Vesole. "Venetoclax-based Induction Therapy for Primary Plasma Cell Leukemia with High BCL-2 Expression." Leukemia & Lymphoma 65, no. 12 (2024): 1901-1904. https://doi.org/10.1080/10428194.2024.2381647.

MLA (8th ed.) Citation

Charalampous, Charalampos, et al. "Venetoclax-based Induction Therapy for Primary Plasma Cell Leukemia with High BCL-2 Expression." Leukemia & Lymphoma, vol. 65, no. 12, 2024, pp. 1901-1904, https://doi.org/10.1080/10428194.2024.2381647.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.